Business News›Markets›Stocks›News›Ayurvedic booster shot may help this FMCG company improve its revenue
Ayurvedic booster shot may help this FMCG company improve its revenue
Synopsis
According to a report by market research firm IMARC, the ayurvedic segment in the country is expected to grow by 14% annually for the next five years.
ET Intelligence Group: Dabur India is expected to be a major beneficiary of rising awareness and demand for ayurvedic and herbal products amid the COVID-19 outbreak and the government’s efforts to bring traditional medicines into the mainstream. The company which earns over one-third of the revenue from ayurvedic segment has reported a strong traction over the past few months in some of its popular offerings – the sales of its chyawanprash
To Read the Full Story, Become an ET Prime Member
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
Access the exclusive Economic Times stories, Editorial and Expert opinion
Why ?
Sharp Insight-rich, Indepth stories across 20+ sectors
Access the exclusive Economic Times stories, Editorial and Expert opinion
Clean experience with
Minimal AdsComment & Engage with ET Prime community Exclusive invites to Virtual Events with Industry Leaders A trusted team of Journalists & Analysts who can best filter signal from noise
